Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Angela Rivers, MD, PhD
Researcher Assistant Professor
Division of Hematology/Oncology
University of Illinois College of Medicine
Outpatient Care Center, Suite 2E
1801 West Taylor Street
Chicago, Illinois, United States
Dr. Rivers is the Director at Sickle Cell Transition Adolescent-Adult Readiness Clinic (STAR) program. Her research interests focus on the Adeno Associated Virus as a vector for gene therapy in sickle cell disease. She has received NIH K08 funding for lab research inducers of fetal hemoglobin. The research (K01 HL103172-01, NIH/ NIHLBI) led by Dr. Rivers focuses on AAV capsid engineering to facilitate expression of therapeutic levels of beta-globin in mouse hematopoietic stem cells. Because everyone is not a candidate for transplantation, successful treatment for sickle cell disease needs to include the development of therapeutic options beside hydroxyurea. Under the mentorship of Dr. Don Lavelle and Dr. Joseph De Simone at the University of Illinois Chicago, the research of Dr. Rivers also focuses on the possible phenotypic correction of sickle disease by induction of hemoglobin F with the combination treatment of Decitabine and novel drugs.
Representative Publications:
Related Content
-
Foundation for Women & Girls with Blood DisordersIn 2010, the Foundation for Women & ...
-
How organ and tissue transplants can affect buying life insuranceEach day in the United States, about 80 ...
-
California Sickle Cell ResourcesThe Comprehensive Sickle Cell Center at ...
-
Montefiore Medical CenterAt the Division of Hematology at Montefi...
-
Aisha Walker, PhDDr. Walker is a Research Assistant Profe...
-
2019 Annual Sickle Cell Symposium – Sickle Cell: Past Present and FutureDRAFT Agenda 5:00pm Registration, netwo...
-
Unanticipated consequences identified after implementation of a pediatric emergency department (PED)-based intranasa...Background: The 2014 National Heart Lun...